Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.

類似資料

• N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
  著者:: Priestman, D, 等
  出版事項: (2008)
• NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
  著者:: Jeyakumar, M, 等
  出版事項: (2004)
• N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
  著者:: Andersson, U, 等
  出版事項: (2000)
• Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
  著者:: Walden, C, 等
  出版事項: (2006)
• The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
  著者:: Fischer, P, 等
  出版事項: (1995)